Meta-Analysis of Randomized Trials Evaluation of Benefit of Gemcitabine-Based Molecular Targeted Therapy for Inoperable Pancreatic Cancer

被引：2
|
作者：
Cao, Yunfei [1 ]
Wu, Liucheng [1 ]
Tan, Aihua [1 ]
Liu, Lidan [1 ]
Gao, Feng [1 ]
机构：
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Colorectal & Anal Surg, Guangxi, Peoples R China
来源：
PANCREAS | 2010年 / 39卷 / 02期
关键词：
ADVANCED PANCREATIC-CANCER; PHASE-III TRIAL; DOUBLE-BLIND; PLACEBO;
D O I：
10.1097/MPA.0b013e3181bdc6b8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：253 / 255
页数：3
相关论文
共 50 条
  • [1] Meta-analysis of randomized trials: Evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer
    Heinemann, Volker
    Boeck, Stefan
    Hinke, Axel
    Labianca, Roberto
    Louvet, Christophe
    [J]. BMC CANCER, 2008, 8 (1)
  • [2] Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer
    Volker Heinemann
    Stefan Boeck
    Axel Hinke
    Roberto Labianca
    Christophe Louvet
    [J]. BMC Cancer, 8
  • [3] Meta-analysis on inoperable pancreatic cancer: A comparison between gemcitabine-based combination therapy and gemcitabine alone
    Xie, De-Rong
    Liang, Han-Lin
    Wang, Yu
    Guo, Shuan-Shuan
    Yang, Qiong
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (43) : 6973 - 6981
  • [4] Meta-analysis on inoperable pancreatic cancer: A comparison between gemcitabine-based combination therapy and gemcitabine alone
    De-Rong Xie
    [J]. World Journal of Gastroenterology, 2006, (43) : 6973 - 6981
  • [5] Gemcitabine-based combination therapy compared with gemcitabine alone for advanced pancreatic cancer: a meta-analysis of nine randomized controlled trials
    Shui-Fang Jin
    Zhao-Kun Fan
    Lei Pan
    Li-Ming Jin
    [J]. Hepatobiliary & Pancreatic Diseases International, 2017, 16 (03) : 236 - 244
  • [6] Gemcitabine-based combination therapy compared with gemcitabine alone for advanced pancreatic cancer: a meta-analysis of nine randomized controlled trials
    Jin, Shui-Fang
    Fan, Zhao-Kun
    Pan, Lei
    Jin, Li-Ming
    [J]. HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2017, 16 (03) : 236 - 244
  • [7] Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: A systematic review and meta-analysis of randomized trials
    Ciliberto, Domenico
    Botta, Cirino
    Correale, Pierpaolo
    Mazzanti, Roberto
    Mantovani, Giovanni
    Tassone, Pierfrancesco
    Tagliaferri, Pierosandro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: A meta-analysis of randomised trials
    Ciliberto, Domenico
    Botta, Cirino
    Correale, Pierpaolo
    Rossi, Marco
    Caraglia, Michele
    Tassone, Pierfrancesco
    Tagliaferri, Pierosandro
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (03) : 593 - 603
  • [9] Comparing gemcitabine-based combination chemotherapy with gemcitabine alone in inoperable pancreatic cancer: A meta-analysis.
    Liang, H
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 335S - 335S
  • [10] Gemcitabine-based combinations for inoperable pancreatic cancer:: Have we made real progress?: A meta-analysis of 20 phase 3 trials
    Bria, Emilio
    Milella, Michele
    Gelibter, Alain
    Cuppone, Federica
    Pino, Maria Simona
    Ruggeri, Enzo Maria
    Carlini, Paolo
    Nistico, Cecilia
    Terzoli, Edmondo
    Cognetti, Francesco
    Giannarelli, Diana
    [J]. CANCER, 2007, 110 (03) : 525 - 533
12345